Article
Embryonic Stem Cells: Overcoming the Immunological Barriers to Cell Replacement Therapy
1 Jan 2009
Abstract excerpt
The appeal of using embryonic stem (ES) cells for regenerative medicine lies in their pluripotency and resulting ability to differentiate into all somatic cell types. While graft rejection remains the greatest hurdle to their use in the clinic, several approaches have been proposed to protect the allogeneic ES cell-derived grafts from host immunity: the creation of nuclear transfer human ES (hES) cell lines; the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
